Estrogen Modulates NFκB Signaling by Enhancing IκBα Levels and Blocking p65 Binding at the Promoters of Inflammatory Genes via Estrogen Receptor-β
Dongqi Xing(University of Alabama at Birmingham), Susan E. Nozell(University of Alabama at Birmingham), Kaizheng Gong(Peking University), Hao Yu(Wenzhou Medical University), Jonathan Black(University of Alabama at Birmingham), Suzanne Oparil(University of Alabama at Birmingham), Wenguang Feng(University of Alabama at Birmingham), Yiu-Fai Chen(University of Alabama at Birmingham)
Cited by 145
Related Papers
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k